Reading Seminars on Health Innovation
These interdisciplinary seminars represent a new step in the development of the I3h Institute, which is now co-directed by Michel Goldman and Mathias Dewatripont. The objective is to stimulate interdisplinary research and reflections about the multiple challenges that healthcare is facing. The participation in the seminar is free of charge. Future sessions will focus on presentations of participants’ own work or of other work deemed particularly relevant for the topic.
If you would like to be included in the e-mail list, please contact awozniak@i3health.eu.
Upcoming seminars
- April 23, 2018 - 13:00 to 15:00
- ULB Solbosch, avenue Paul Heger 6, building H, room H.3.366 Brussels
- Novel approaches to pricing and reimbursement for innovative medicines
Lieven Annemans Professor of Health Economics at the Medical Faculty of Ghent University
Previous seminars
- April 09, 2018
- Value assessment and reimbursement: the (special?) case of orphan drugs
Steven Simoens Professor at the Faculty of Pharmaceutical Sciences (KU Leuven)
- March 19, 2018
- Subgroup and post-hoc analyses in clinical trials: the truth lies in the eye of the beholder
Bruno Flamion MD, PhD, Professor of Clinical Pharmacology (UNamur) and VP Head Strategic Development (Idorsia Pharmaceuticals)
- March 05, 2018
- Are ideas getting harder to find?
Øyvind Aas Post-doctoral researcher at ECARES, ULB
- February 26, 2018
- Economic value of vaccines for the developing world: different perspectives
Bill Hausdorff Senior Lecturer at Faculté de Médecine ULB, Independent Consultant
- February 12, 2018
- Awareness and AIDS: A Political Economy Perspective
by Gani Aldashev Professor at ULB
- January 29, 2018
- The opioid crisis: what went wrong? Crossing medical and economic perspectives.
Maurice Sosnowski MD, professor at ULB and Mathias Dewatripont PhD, Co-director of I3h, professor of Economics at ULB
- January 15, 2018
- The Unexpected Consequences of Asymmetric Competition: An Application to the Pharmaceutical Industry.
Micael Castanheira PhD, Director for Research at FRS-FNRS
- December 11, 2017
- Redefining health policy for effective coverage: Where do we stand in Tuberculosis control?
Samia Laokri PhD, Assistant Professor at ULB
- November 27, 2017
- Do regulatory agencies hamper therapeutic innovation?
Mathias Dewatripont PhD, Co-director of I3h, professor of Economics at ULB
- November 13, 2017
- The changing face of clinical trials and their impact on industrial R&D
Michel Goldman MD, PhD, Co-director I3h , professor at ULB and Chief Editor of ‘Frontiers in Medicine’